These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24307515)

  • 21. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.
    Bisio V; Zampini M; Tregnago C; Manara E; Salsi V; Di Meglio A; Masetti R; Togni M; Di Giacomo D; Minuzzo S; Leszl A; Zappavigna V; Rondelli R; Mecucci C; Pession A; Locatelli F; Basso G; Pigazzi M
    Leukemia; 2017 Apr; 31(4):974-977. PubMed ID: 27890935
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
    Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
    Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inv(11)(p15q22)/NUP98-DDX10 fusion and isoforms in a new case of de novo acute myeloid leukemia.
    Gorello P; Nofrini V; Brandimarte L; Pierini V; Crescenzi B; Nozza F; Daniele G; Storlazzi CT; Di Giacomo D; Matteucci C; La Starza R; Mecucci C
    Cancer Genet; 2013 Mar; 206(3):92-6. PubMed ID: 23522748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
    Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion.
    Meech SJ; McGavran L; Odom LF; Liang X; Meltesen L; Gump J; Wei Q; Carlsen S; Hunger SP
    Blood; 2001 Aug; 98(4):1209-16. PubMed ID: 11493472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26).
    Fujisawa S; Tanabe J; Harano H; Kanamori H; Motomura S; Mohri H; Ishigatsubo Y
    Leuk Lymphoma; 1999 Nov; 35(5-6):627-30. PubMed ID: 10609803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique structural abnormality of chromosome 16 resulting in a CBF beta-MYH11 fusion transcript in a patient with acute myeloid leukemia, FAB M4.
    O'Reilly J; Chipper L; Springall F; Herrmann R
    Cancer Genet Cytogenet; 2000 Aug; 121(1):52-5. PubMed ID: 10958941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
    Takeuchi K; Soda M; Togashi Y; Ota Y; Sekiguchi Y; Hatano S; Asaka R; Noguchi M; Mano H
    Haematologica; 2011 Mar; 96(3):464-7. PubMed ID: 21134980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.
    Kozu Y; Isaka M; Ohde Y; Takeuchi K; Nakajima T
    Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):191-4. PubMed ID: 23345154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
    Mangaru Z; Shetty S; Visconte V; Liu HD; Rogers HJ
    Am J Hematol; 2016 Jun; 91(4):E273-4. PubMed ID: 26719044
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).
    Kenealy M; Patton N; Filshie R; Nicol A; Ho SJ; Hertzberg M; Mills T; Prosser I; Link E; Cowan L; Zannino D; Seymour JF
    Leuk Lymphoma; 2017 Feb; 58(2):298-307. PubMed ID: 27268068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel fusion of TPR and ALK in lung adenocarcinoma.
    Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
    J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
    Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
    Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
    Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
    Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
    Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Spagnoli A; Voso MT; Fianchi L; Papayannidis C; Gaidano GL; Breccia M; Musto P; De Bellis E; Del Principe MI; Lunghi M; Lessi F; Martinelli G; Venditti A
    Ann Hematol; 2018 Oct; 97(10):1767-1774. PubMed ID: 29947973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
    Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
    Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.